Rheumatoid arthritis drug reduces risk of death for severely ill Covid-19 patients

The preliminary results came from the RECOVERY trial, which has been testing potential Covid-19 treatments since March 2020. Tocilizumab was added to the trial in April 2020. The results were shared in a preprint, but have not yet been peer-reviewed or published in a medical journal. For the trial, 2,022 patients were randomly allocated tocilizumab …